Santhera Pharmaceuticals Holding AG/Fr. SANN
07:00
09:05
11:10
13:15
15:20
1D1W1MYTD1Y5YMAX
About Santhera Pharmaceuticals Holding AG
Ticker
Fr. SANN
Sector
Primary listing
XSWX
Employees
79
Headquarters
Pratteln, Switzerland
Website
SANN Metrics
BasicAdvanced
CHF 224M
-
-CHF 5.41
-0.74
-
Price and volume
Market cap
CHF 224M
Beta
-0.74
52-week high
CHF 17.74
52-week low
CHF 9.38
Average daily volume
94K
Financial strength
Current ratio
1.018
Quick ratio
0.512
Long term debt to equity
-1,318.182
Total debt to equity
-1,608.35
Interest coverage (TTM)
-3.65%
Profitability
EBITDA (TTM)
-45.631
Gross margin (TTM)
13.41%
Net profit margin (TTM)
-133.72%
Operating margin (TTM)
-103.75%
Effective tax rate (TTM)
-0.33%
Revenue per employee (TTM)
CHF 620,000
Management effectiveness
Return on assets (TTM)
-26.60%
Return on equity (TTM)
-288.14%
Valuation
Price to revenue (TTM)
4.032
Price to book
-81.25
Price to tangible book (TTM)
-3.02
Price to free cash flow (TTM)
-4.815
Free cash flow yield (TTM)
-20.77%
Free cash flow per share (TTM)
-3.385
Growth
Revenue change (TTM)
-56.85%
Earnings per share change (TTM)
-194.97%
3-year revenue growth (CAGR)
569.96%
10-year revenue growth (CAGR)
31.31%
3-year earnings per share growth (CAGR)
-24.51%
10-year earnings per share growth (CAGR)
-13.30%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Santhera Pharmaceuticals Holding AG stock?
Santhera Pharmaceuticals Holding AG (SANN) has a market cap of Fr.224M as of April 05, 2026.
What is the P/E ratio for Santhera Pharmaceuticals Holding AG stock?
The price to earnings (P/E) ratio for Santhera Pharmaceuticals Holding AG (SANN) stock is 0 as of April 05, 2026.
Does Santhera Pharmaceuticals Holding AG stock pay dividends?
No, Santhera Pharmaceuticals Holding AG (SANN) stock does not pay dividends to its shareholders as of April 05, 2026.
When is the next Santhera Pharmaceuticals Holding AG dividend payment date?
Santhera Pharmaceuticals Holding AG (SANN) stock does not pay dividends to its shareholders.
What is the beta indicator for Santhera Pharmaceuticals Holding AG?
Santhera Pharmaceuticals Holding AG (SANN) has a beta rating of -0.74. This means that it has an inverse relation to market volatility.